Corcept Therapeutics Inc. (CORT)
Corcept Therapeutics Inc. (CORT) Insider Trading
Directors, officers and holders of more than 10% of CORT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 721 transactions on file: 0 with code P, 24 with code S and 26 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | WILSON JAMES N | Director | S Sale | 6,654 | $114.48 | $761,717 |
| Oct 15, 2026 | WILSON JAMES N | Director | S Sale | 300 | $116.30 | $34,889 |
| Oct 15, 2026 | WILSON JAMES N | Director | S Sale | 3,046 | $115.39 | $351,476 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 8,333 | Not measured | Not measured |
| Oct 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 2,086 | $115.73 | $241,412 |
| Oct 2, 2026 | Maduck Sean | See Remarks | S Sale | 8,744 | $116.55 | $1,019,143 |
| Oct 2, 2026 | Maduck Sean | See Remarks | M Exercise | 24,587 | Not measured | Not measured |
| Oct 2, 2026 | Maduck Sean | See Remarks | M Exercise | 24,587 | $8.27 | $203,334 |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 5,833 | $19.26 | $112,344 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 5,147 | $116.58 | $600,063 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 8,333 | $21.63 | $180,243 |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 3,357 | Not measured | Not measured |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 5,833 | Not measured | Not measured |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | S Sale | 4,446 | $115.70 | $514,389 |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 3,357 | $13.56 | $45,521 |
| Oct 2, 2026 | Lyon Joseph Douglas | See Remarks | S Sale | 4,744 | $116.54 | $552,869 |
| Oct 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 1,100 | $114.52 | $125,973 |
| Oct 2, 2026 | Maduck Sean | See Remarks | S Sale | 15,843 | $116.12 | $1,839,741 |
| Oct 1, 2026 | Maduck Sean | See Remarks | M Exercise | 413 | Not measured | Not measured |
| Oct 1, 2026 | Maduck Sean | See Remarks | S Sale | 413 | $115.54 | $47,717 |
| Oct 1, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 810 | $13.56 | $10,984 |
| Oct 1, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 810 | Not measured | Not measured |
| Oct 1, 2026 | Lyon Joseph Douglas | See Remarks | S Sale | 810 | $115.40 | $93,473 |
| Oct 1, 2026 | Gunn Justin Frederick | See Remarks | A Award | 100,000 | Not measured | Not measured |
| Oct 1, 2026 | Maduck Sean | See Remarks | M Exercise | 413 | $8.27 | $3,416 |
| Sep 24, 2026 | Robb Gary Charles | Chief Business Officer | G Gift | 17,100 | Not measured | Not measured |
| Sep 24, 2026 | Robb Gary Charles | Chief Business Officer | G Gift | 5,000 | Not measured | Not measured |
| Sep 24, 2026 | Robb Gary Charles | Chief Business Officer | G Gift | 5,000 | Not measured | Not measured |
| Sep 17, 2026 | Robb Gary Charles | Chief Business Officer | M Exercise | 17,493 | Not measured | Not measured |
| Sep 17, 2026 | Robb Gary Charles | Chief Business Officer | M Exercise | 17,493 | $8.27 | $144,667 |
| Sep 16, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 296 | $100.82 | $29,843 |
| Sep 15, 2026 | WILSON JAMES N | Director | S Sale | 400 | $110.84 | $44,335 |
| Sep 15, 2026 | WILSON JAMES N | Director | S Sale | 2,800 | $111.70 | $312,771 |
| Sep 15, 2026 | WILSON JAMES N | Director | S Sale | 6,800 | $110.27 | $749,835 |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 2,596 | $11.35 | $29,465 |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 7,404 | $13.56 | $100,398 |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 7,404 | Not measured | Not measured |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | S Sale | 2,188 | $114.12 | $249,686 |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | S Sale | 7,812 | $113.32 | $885,261 |
| Sep 14, 2026 | Lyon Joseph Douglas | See Remarks | M Exercise | 2,596 | Not measured | Not measured |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | F Tax Payment | 102 | $113.38 | $11,565 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | M Exercise | 58,333 | $21.63 | $1,261,743 |
| Sep 2, 2026 | Lyon Joseph Douglas | See Remarks | F Tax Payment | 72 | $113.38 | $8,163 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 1,537 | $111.37 | $171,181 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 974 | $112.40 | $109,474 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 1,225 | $115.44 | $141,413 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 23,600 | $109.35 | $2,580,674 |
| Sep 2, 2026 | Robb Gary Charles | Chief Business Officer | F Tax Payment | 91 | $113.38 | $10,318 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 23,770 | $110.70 | $2,631,349 |
| Sep 2, 2026 | Vieira Roberto Wandenkolk | President, Oncology | S Sale | 1,606 | $113.72 | $182,632 |
The full Form 4 history is on the CORT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.